VIROLOGICA SINICA

Scope & Guideline

Illuminating the Pathways of Infectious Disease Research

Introduction

Welcome to your portal for understanding VIROLOGICA SINICA, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1674-0769
PublisherKEAI PUBLISHING LTD
Support Open AccessNo
CountryChina
TypeJournal
Convergefrom 2006 to 2024
AbbreviationVIROL SIN / Virol. Sin.
Frequency6 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
Address16 DONGHUANGCHENGGEN NORTH ST, Building 5, Room 411, BEIJING, DONGCHENG DISTRICT 100009, PEOPLES R CHINA

Aims and Scopes

VIROLOGICA SINICA is a leading journal dedicated to the study of virology, encompassing a broad range of topics related to viruses, their interactions with host organisms, and the development of antiviral strategies. The journal aims to provide a platform for disseminating cutting-edge research and advances in the field of virology, focusing on both basic and applied science.
  1. Viral Pathogenesis and Host Interaction:
    Research focused on understanding the mechanisms by which viruses cause disease in their hosts, including studies on immune responses and the molecular interactions between viral components and host cells.
  2. Viral Genetics and Evolution:
    Investigating the genetic diversity, evolution, and epidemiology of viruses, including studies on mutations, reassortments, and phylogenetic analyses that elucidate viral transmission dynamics.
  3. Antiviral Drug Development and Vaccinology:
    Development and testing of antiviral agents and vaccines, including novel therapeutic approaches, vaccine efficacy studies, and the mechanisms of action of antiviral compounds.
  4. Emerging and Re-emerging Viruses:
    Research focused on newly identified viruses or those that are re-emerging, including zoonotic viruses, and their implications for public health.
  5. Vector Biology and Virus Transmission:
    Studies on the role of vectors in the transmission of viruses, including ecological and environmental factors that influence vector-host interactions.
  6. Technological Innovations in Virology:
    Application of novel technologies in virology research, including high-throughput screening, genomic sequencing, and bioinformatics approaches to study viral infections.
In response to the ever-evolving landscape of virology, certain themes have gained traction in recent publications within VIROLOGICA SINICA. This section outlines the emerging scopes that reflect contemporary challenges and innovations in the field.
  1. COVID-19 Research:
    Research related to SARS-CoV-2 and COVID-19 has surged, encompassing studies on viral variants, immune responses, vaccine development, and long-term effects of infection.
  2. Viral Zoonoses and Cross-Species Transmission:
    There is an increasing focus on viruses that jump from animals to humans, highlighting the need to understand zoonotic diseases and their public health implications.
  3. Antiviral Drug Repurposing:
    The exploration of existing drugs for new antiviral applications has become prominent, particularly in light of the urgent need for effective treatments against emerging viruses.
  4. Host-Pathogen Interactions:
    Research examining the intricate interactions between viruses and their hosts is expanding, with a focus on immune evasion strategies and host susceptibility factors.
  5. Metagenomics and Viral Diversity:
    The use of metagenomic approaches to explore viral diversity in various environments (e.g., human, animal, and environmental samples) is increasingly prevalent, revealing new viral species and their potential impacts.

Declining or Waning

While VIROLOGICA SINICA continues to thrive in many areas, certain themes have shown a decline in focus over recent years. This section highlights those themes that are becoming less prominent in the journal's publications.
  1. Traditional Virology Methods:
    There appears to be a waning interest in traditional virology techniques, such as classical culture methods for virus isolation, as newer molecular and high-throughput techniques gain prominence.
  2. Non-pathogenic Viral Studies:
    Research on non-pathogenic viruses or those with limited clinical relevance is decreasing, possibly due to a shift towards studies with direct implications for human health.
  3. Basic Studies of Viral Structure:
    While structural virology is still important, there has been a noticeable decrease in the number of publications that focus solely on the basic structural characteristics of viruses without linking them to functional or pathogenic outcomes.

Similar Journals

Molecular Genetics Microbiology and Virology

Illuminating the Complexities of Microbial Genetics
Publisher: PLEIADES PUBLISHING INCISSN: 0891-4168Frequency: 4 issues/year

Molecular Genetics Microbiology and Virology is an esteemed academic journal published by PLEIADES PUBLISHING INC, specializing in the complex interplay of genetics, microbiology, and virology. Established in 2007, this journal serves as a crucial platform for researchers and professionals committed to advancing our understanding of infectious diseases and molecular biology. Despite its current categorization in Q4 across several fields, the journal aims to evolve and foster significant discourse within the scientific community. While not an open access journal, it provides essential insights and high-quality research articles that contribute to the body of knowledge in molecular genetics and related disciplines. Located in the vibrant research landscape of New York, USA, the journal also encourages new submissions that address cutting-edge research topics and emerging trends in infectious diseases, thereby appealing to both emerging scholars and seasoned experts alike.

ANTIVIRAL RESEARCH

Advancing the Frontiers of Antiviral Science
Publisher: ELSEVIERISSN: 0166-3542Frequency: 12 issues/year

ANTIVIRAL RESEARCH, published by Elsevier, stands at the forefront of the study of antiviral agents and therapy, with a dedicated focus on advancing the understanding of viral infections and their mechanisms. The journal is recognized within the top tier of academic publications, belonging to the prestigious Q1 category in both Pharmacology and Virology as of 2023, ranking 12th out of 313 in Pharmacology and 11th out of 80 in Virology according to Scopus metrics, reflecting its significant impact in the field. With a long-standing history since its inception in 1959, it continues to serve as an essential platform for researchers and health professionals alike, sharing critical findings that drive innovation in antiviral therapeutics. Although it does not currently offer open access options, the journal’s rigorous peer-review process ensures that every published article meets high academic standards, providing invaluable insights for those dedicated to enhancing public health through virology research.

Journal of Clinical Virology Plus

Bridging research and application for viral breakthroughs.
Publisher: ELSEVIERISSN: 2667-0380Frequency: 4 issues/year

The Journal of Clinical Virology Plus, published by Elsevier, is an essential resource for researchers and professionals in the fields of virology and infectious diseases. Launched in 2021, this journal aims to bridge the gap between clinical research and application, fostering a deeper understanding of viral pathogenesis, diagnostics, and therapeutic strategies. With an ISSN of 2667-0380, this open-access journal brings cutting-edge findings to the global scientific community, facilitating the rapid dissemination of knowledge critical for advancing public health. Positioned in the Q3 category for both Infectious Diseases and Virology in 2023, its ranking reflects its growing influence and relevance in the academic landscape. The journal strives to support innovative research, collaborative studies, and comprehensive reviews that address contemporary challenges in clinical virology. As it converges through the years from 2021 to 2024, Journal of Clinical Virology Plus aims to be a central hub for vital discussions and breakthroughs in this dynamic field.

JOURNAL OF MEDICAL VIROLOGY

Cutting-edge Insights: Your Gateway to the Latest in Virology.
Publisher: WILEYISSN: 0146-6615Frequency: 12 issues/year

JOURNAL OF MEDICAL VIROLOGY is a prestigious academic publication dedicated to advancing the field of virology and infectious diseases. Published by WILEY, this journal has established itself as a cornerstone within the scientific community since its inception in 1977, and it will continue to provide cutting-edge research until 2024. With an impressive impact factor that places it in the Q1 quartile for both Infectious Diseases and Virology, the journal ranks 14 out of 344 in Medicine - Infectious Diseases and 6 out of 80 in Immunology and Microbiology - Virology according to Scopus metrics. Its focus encompasses a broad spectrum of topics, including viral pathogenesis, diagnostics, treatment strategies, and epidemiology, making it an essential resource for researchers, clinicians, and students alike. Although not an open-access journal, it provides valuable insights and accessible content for subscribers and libraries. The ongoing commitment to high-quality peer-reviewed articles makes JOURNAL OF MEDICAL VIROLOGY a vital platform for disseminating knowledge and fostering innovation in virology and related fields.

Viruses-Basel

Elevating Knowledge in Virology and Public Health
Publisher: MDPIISSN: Frequency: 12 issues/year

Viruses-Basel, published by MDPI, is a leading interdisciplinary journal focused on the field of virology and infectious diseases, offering a platform for the rapid dissemination of high-quality research. Established in 2009, this open access journal has become an essential resource for researchers and health professionals, ensuring that critical findings are readily available to a global audience. With an impressive Q1 ranking in Infectious Diseases and a Q2 ranking in Virology as of 2023, the journal reflects its commitment to impactful research, validated by its notable positions within Scopus categories—ranked #84 out of 344 in Medicine: Infectious Diseases and #27 out of 80 in Immunology and Microbiology: Virology. The journal adheres to high standards of academic rigor, and by embracing an open access model, it promotes unrestricted access to scientific knowledge, fostering collaboration among researchers, professionals, and students alike. Situated in Basel, Switzerland, the journal serves as a cornerstone in the dissemination of research findings related to viral diseases and their implications on public health.

Microbiology Spectrum

Fostering collaboration through open access innovation.
Publisher: AMER SOC MICROBIOLOGYISSN: 2165-0497Frequency: 6 issues/year

Microbiology Spectrum is a prominent peer-reviewed journal published by the American Society for Microbiology, dedicated to advancing the field of microbiology through the dissemination of high-quality research. Since its inception in 2013 and continuing until 2024, the journal has established a strong presence in key domains such as microbiology, immunology, cell biology, and ecology, achieving impressive quartile rankings including Q1 in Infectious Diseases and Q1 in Immunology and Microbiology as of 2023. With an emphasis on open access to its scholarly content, Microbiology Spectrum aims to foster collaboration and knowledge sharing among researchers, professionals, and students alike. The journal's scope encompasses a diverse range of topics pertinent to the field, making it an essential resource for anyone involved in microbiological research and its applications. Researchers looking to publish their findings in a respected journal will find Microbiology Spectrum's robust impact factor and Scopus rankings serve as testament to its significance and influence within the academic community.

Journal of Virology

Pioneering Discoveries in Viral Pathogenesis
Publisher: AMER SOC MICROBIOLOGYISSN: 0022-538XFrequency: 12 issues/year

Journal of Virology is a premier scholarly journal dedicated to advancing the field of virology, focusing on the molecular mechanisms of virus-host interactions, viral pathogenesis, and the latest therapeutic and vaccine developments. Published by the American Society for Microbiology, this esteemed journal has been a cornerstone for researchers since its inception in 1967, providing a platform for high-quality, peer-reviewed research. With a commendable impact factor indicative of its relevance and influence, the journal is categorized in the top quartile (Q1) for Virology, Microbiology, and Insect Science, reflecting its significance in these fields. Researchers can access a wealth of studies and findings that shape our understanding of viruses and their interactions with hosts, highlighting its role in both basic and applied sciences. Positioned in the United States, the Journal of Virology serves a global audience, ensuring that cutting-edge discoveries reach professionals, students, and academics alike. Join the conversation as we explore the complexities of virology and its implications for human health and disease.

VIROLOGIE

Innovating insights in virology and treatment.
Publisher: JOHN LIBBEY EUROTEXT LTDISSN: 1267-8694Frequency: 6 issues/year

VIROLOGIE is a prominent international journal dedicated to advancing the field of virology and infectious diseases, published by John Libbey Eurotext Ltd. Since its inception in 1997, this journal has provided a platform for researchers and professionals to disseminate their findings on various aspects of virology, including the pathogenesis, epidemiology, and treatment of viral infections. Despite its current ranking in Q4 for both Infectious Diseases and Virology categories, the journal remains a valuable resource for emerging research and novel insights. The ISSN for the journal is 1267-8694, and it is based in France. VIROLOGIE is committed to upholding rigorous academic standards and fosters an inclusive scholarly community, making it an essential read for those pursuing knowledge and advancements in the ever-evolving landscape of virology. While the journal does not currently offer open access options, it continues to contribute significantly to the global discourse on viral research through its diverse range of published studies.

JOURNAL OF VIROLOGICAL METHODS

Advancing virology through innovative methodologies.
Publisher: ELSEVIERISSN: 0166-0934Frequency: 16 issues/year

Journal of Virological Methods, published by Elsevier, is a prominent peer-reviewed journal dedicated to advancing the methodologies employed in virology research. Since its inception in 1980, this esteemed journal has become a vital resource for researchers, professionals, and students focused on the intricate study of viruses and viral-related diseases. With a current ISSN of 0166-0934 and an E-ISSN of 1879-0984, this journal strives to present innovative techniques and tools that enhance our understanding of virology. Designed for a global audience, it operates in a rigorous academic environment, as reflected by its 2023 Scopus ranking of #40 in the Virology category and its Q3 quartile placement. The journal is committed to fostering open dialogue and collaboration within the scientific community, ultimately contributing to the development of novel strategies and interventions against viral infections. By offering comprehensive insights into virological methodologies, the Journal of Virological Methods continuously serves as a cornerstone for those dedicated to exploring the complexities of viral research.

JOURNAL OF GENERAL VIROLOGY

Fostering critical discussions in virology research.
Publisher: MICROBIOLOGY SOCISSN: 0022-1317Frequency: 12 issues/year

The JOURNAL OF GENERAL VIROLOGY, published by the Microbiology Society, is a premier academic journal dedicated to advancing the field of virology. Established in 1967, this influential journal covers a wide spectrum of research from basic virology to applied studies, serving as a vital resource for researchers, professionals, and students alike. With its ISSN 0022-1317 and E-ISSN 1465-2099, the journal is recognized for its rigorous peer-review process and high-quality publications, attaining a commendable Q2 ranking in the Virology category for 2023. The journal's focus on disseminating innovative findings and fostering critical discussions contributes significantly to the understanding of viral mechanisms, disease processes, and potential therapeutic strategies. Although it does not currently offer Open Access options, the journal remains accessible to the academic community, with a strong commitment to supporting virology research globally. As part of Scopus' top-tier rankings, illustrating its impact within the category of Immunology and Microbiology, the JOURNAL OF GENERAL VIROLOGY continues to play a pivotal role in shaping the future of virological science.